| Study of Oral HRS-5346 in Adult Patients With Elevated Lipoprotein(a) and High Risk of Cardiovascular Events (NCT07767513) | Shandong Suncadia Medicine Co., Ltd. | 2026-09-01 |
| Phase I Clinical Study Evaluating the Relative Bioavailability of Different Formulations of HRS-5346 in Healthy Participants (NCT07752069) | Shandong Suncadia Medicine Co., Ltd. | 2026-08-01 |
| A Trial of HRS-1780 in Participants With Uncontrolled Hypertension or Resistant Hypertension. (NCT07708441) | Shandong Suncadia Medicine Co., Ltd. | 2026-07-01 |
| Renal Efficacy and Safety of the Novel Oral Small-Molecule GLP-1RA HRS-7535 Evaluated in Participants With Chronic Kidney Disease (NCT07625774) | Shandong Suncadia Medicine Co., Ltd. | 2026-07-01 |
| Clinical Study of HRS-2129 for Acute Gouty Arthritis (NCT07706777) | Shandong Suncadia Medicine Co., Ltd. | 2026-07-01 |
| A Clinical Study of HRS-7156 in Healthy Participants (NCT07601087) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-12 |
| A Study to Assess the Effect of HRS-1301 on the Pharmacokinetics of Midazolam and Atorvastatin in Healthy Participants (NCT07608705) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-08 |
| An Open-label, Multicenter, Phase II Clinical Study to Evaluate HRS-7058 in Patients With Pancreatic Cancer (NCT07589569) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-04 |
| A Clinical Study Comparing the Bioavailability of HRS-2189 Tablets (NCT07639905) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-01 |
| A Trial of HRS-7058 in Advanced or Metastatic Non-Small Cell Lung Cancer Patients Who Have Failed Standard Treatment (NCT07601048) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-01 |
| Human Mass Balance Study of [¹⁴C]HRS-1893 (NCT07656779) | Shandong Suncadia Medicine Co., Ltd. | 2026-06-01 |
| Phase III Study of HRS-7535 for Hypertension With Overweight or Obesity (NCT07528027) | Shandong Suncadia Medicine Co., Ltd. | 2026-05-29 |
| A Study to Evluate Efficacy and Safety of HRS-8080 Combined With Dalpiciclib in Patients With Advanced or Metastatic Breast Cancer Resistant to Adjuvant Endocrine Therapy. (NCT07354022) | Shandong Suncadia Medicine Co., Ltd. | 2026-05-05 |
| A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects (NCT07557407) | Shandong Suncadia Medicine Co., Ltd. | 2026-05-01 |
| A Phase II Clinical Study on the Efficacy and Safety of HRS-1780 in Participants With Primary Aldosteronism (NCT07470983) | Shandong Suncadia Medicine Co., Ltd. | 2026-04-23 |
| A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants (NCT07479641) | Shandong Suncadia Medicine Co., Ltd. | 2026-04-14 |
| A Phase II Clinical Trial of HRS-1893 in the Treatment of Heart Failure With Preserved Ejection Fraction (NCT07269717) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-30 |
| A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer (NCT07389733) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-27 |
| A Study of HRS-2129 in Patients With Diabetic Peripheral Neuropathic Pain (NCT07377721) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-24 |
| A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease (NCT07419828) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-13 |
| A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritis (NCT07351968) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-10 |
| A Phase III Trial Comparing HRS-8080 With Standard Endocrine Therapy in Patients With Intermediate or High Risk Early Breast Cancer (NCT07349069) | Shandong Suncadia Medicine Co., Ltd. | 2026-03-04 |
| A Study of HRS-1301 Tablets in Healthy Subjects and Those With Impaired Kidney Function (NCT07322016) | Shandong Suncadia Medicine Co., Ltd. | 2026-01-13 |
| A Study to Assess the Mass Balance of [14C]HRS-8080 in Healthy Chinese Postmenopausal Female Subjects. (NCT07320521) | Shandong Suncadia Medicine Co., Ltd. | 2026-01-09 |
| A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects (NCT07272330) | Shandong Suncadia Medicine Co., Ltd. | 2025-12-11 |
| A Study to Evaluate the Drug Interactions of HRS-7535 With Acetaminophen, Digoxin, Rosuvastatin, and Omeprazole in Obese or Overweight Subjects (NCT07269756) | Shandong Suncadia Medicine Co., Ltd. | 2025-12-07 |
| A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants (NCT07229560) | Shandong Suncadia Medicine Co., Ltd. | 2025-11-26 |
| A Phase II Study To Evaluate the Efficacy And Safety Of HRS-1301 In Participants With Dyslipidemia (NCT07229937) | Shandong Suncadia Medicine Co., Ltd. | 2025-11-25 |
| A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery (NCT07185594) | Shandong Suncadia Medicine Co., Ltd. | 2025-10-24 |
| A Phase 2 Clinical Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of HRS-7085 Tablets in Patients With Inflammatory Bowel Disease (NCT07229950) | Shandong Suncadia Medicine Co., Ltd. | 2025-10-17 |
| A Clinical Trial of HRS-1301 on the Pharmacokinetics of Rosuvastatin Calcium Tablets in Healthy Subjects (NCT07097831) | Shandong Suncadia Medicine Co., Ltd. | 2025-10-09 |
| A Phase III Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (NCT07021976) | Shandong Suncadia Medicine Co., Ltd. | 2025-08-11 |
| A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer (NCT07024173) | Shandong Suncadia Medicine Co., Ltd. | 2025-07-23 |
| A Clinical Trial of HRS-7058 Combined Anti-tumor Drugs in Subjects With Solid Tumors (NCT07032077) | Shandong Suncadia Medicine Co., Ltd. | 2025-07-09 |
| A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy (NCT07021963) | Shandong Suncadia Medicine Co., Ltd. | 2025-07-04 |
| Investigation of Pharmacokinetics and Safety of HRS-7535 in Subjects With Hepatic Impairment and Normal Hepatic Function (NCT06961643) | Shandong Suncadia Medicine Co., Ltd. | 2025-06-05 |
| A Phase II Clinical Study of HRS-7058 in Combination With Antitumor Drugs in Patients With Advanced Malignant Tumour (NCT06915142) | Shandong Suncadia Medicine Co., Ltd. | 2025-04-28 |
| A Trial of HRS-7535 Tablets in Subjects With Overweight or Obesity (NCT06904105) | Shandong Suncadia Medicine Co., Ltd. | 2025-04-10 |
| Study on the Efficacy and Safety of HRS-7535 in Patients With Mild Decrease in Ejection Fraction/Preserved Ejection Fraction Heart Failure and Obesity (NCT06820099) | Shandong Suncadia Medicine Co., Ltd. | 2025-04-10 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-1301 in Healthy Subjects (NCT06857253) | Shandong Suncadia Medicine Co., Ltd. | 2025-03-18 |
| Clinical Study of HRS-2129 for Postoperative Analgesia in Orthopaedics (NCT06780267) | Shandong Suncadia Medicine Co., Ltd. | 2025-03-11 |
| A Clinical Study of Mass Balance of [14C]HRS-7535 (NCT06819488) | Shandong Suncadia Medicine Co., Ltd. | 2025-02-27 |
| A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy (NCT06816251) | Shandong Suncadia Medicine Co., Ltd. | 2025-02-25 |
| A Study of HRS-5346 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular Events (NCT06816264) | Shandong Suncadia Medicine Co., Ltd. | 2025-02-18 |
| A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients (NCT06679036) | Shandong Suncadia Medicine Co., Ltd. | 2025-01-21 |
| Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human (NCT06727838) | Shandong Suncadia Medicine Co., Ltd. | 2024-12-31 |
| A Multiple Ascending Dose Trial of HRS-2129 in Healthy Subjects (NCT06742840) | Shandong Suncadia Medicine Co., Ltd. | 2024-12-30 |
| Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects (NCT06671821) | Shandong Suncadia Medicine Co., Ltd. | 2024-11-20 |
| A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects (NCT06621316) | Shandong Suncadia Medicine Co., Ltd. | 2024-10-30 |
| A Single Dose Escalation Trial of HRS-2129 in Healthy Subjects (NCT06619392) | Shandong Suncadia Medicine Co., Ltd. | 2024-10-17 |
| A Study of HRS-7535 Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Metformin (NCT06589765) | Shandong Suncadia Medicine Co., Ltd. | 2024-09-27 |
| A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise (NCT06672172) | Shandong Suncadia Medicine Co., Ltd. | 2024-09-25 |
| A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy (NCT06516068) | Shandong Suncadia Medicine Co., Ltd. | 2024-08-11 |
| Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets in Healthy Human (NCT06495931) | Shandong Suncadia Medicine Co., Ltd. | 2024-07-15 |
| Safety and Tolerance of Increased Doses of HRS-5346 Tablets in Healthy Subjects (NCT06441227) | Shandong Suncadia Medicine Co., Ltd. | 2024-06-13 |
| A Phase I Clinical Study of HRS-7058 in Patients With Advanced Malignant Tumour (NCT06383871) | Shandong Suncadia Medicine Co., Ltd. | 2024-06-06 |
| Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects (NCT06422039) | Shandong Suncadia Medicine Co., Ltd. | 2024-05-23 |
| Efficacy and Safety of HRS-7535 Tablets in T2DM Subjects Poorly Controlled With Metformin and SGLT2i. (NCT06393348) | Shandong Suncadia Medicine Co., Ltd. | 2024-05-17 |
| Effect of Verapamil Tablets on the Pharmacokinetic of HRS-1893 Tablets in Healthy Subjects (NCT06354556) | Shandong Suncadia Medicine Co., Ltd. | 2024-04-26 |
| Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects (NCT06344936) | Shandong Suncadia Medicine Co., Ltd. | 2024-04-01 |
| Efficacy and Safety of HRS-1780 Tablets and Henagliflozin Proline Tablets in Patients With Chronic Kidney Disease (NCT06221059) | Shandong Suncadia Medicine Co., Ltd. | 2024-03-02 |
| Efficacy and Safety of HRS-7535 Tablets in Obese Subjects . (NCT06250946) | Shandong Suncadia Medicine Co., Ltd. | 2024-02-23 |
| Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer (NCT06222879) | Shandong Suncadia Medicine Co., Ltd. | 2024-02-20 |
| Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects (NCT06132204) | Shandong Suncadia Medicine Co., Ltd. | 2023-12-21 |
| A Randomized, Double-Blind, Dose-Escalation, Placebo-Controlled Phase I Clinical Trial Investigating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Oral Doses of HRS-7085 Tablets in Healthy Subjects, With Assessment of Food Effects (NCT06175949) | Shandong Suncadia Medicine Co., Ltd. | 2023-12-01 |
| Safety and Pharmacokinetics of HRS-1780 in Healthy Subjects and Subjects With Impaired Renal Function (NCT06039254) | Shandong Suncadia Medicine Co., Ltd. | 2023-09-01 |
| A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy (NCT05879523) | Shandong Suncadia Medicine Co., Ltd. | 2023-06-05 |
| Phase I Clinical Study of HRS-2189 in the Treatment of Patients With Advanced Malignant Tumors (NCT05851092) | Shandong Suncadia Medicine Co., Ltd. | 2023-05-26 |
| A 16 Week Study of HRS-7535 in Adults With Type 2 Diabetes Mellitus (NCT05759897) | Shandong Suncadia Medicine Co., Ltd. | 2023-02-28 |
| A Trial of HRS-1358 Tablets in Metastatic or Local Advanced Breast Cancer (NCT05628870) | Shandong Suncadia Medicine Co., Ltd. | 2023-02-07 |
| Safety and Tolerance of Increased Doses of HRS-1780 Tablets in Healthy Subjects (NCT05638126) | Shandong Suncadia Medicine Co., Ltd. | 2023-02-02 |
| A HR20031 BE Study on Healthy Subjects (NCT05682495) | Shandong Suncadia Medicine Co., Ltd. | 2023-01-31 |
| A HR20031 FE Study on Healthy Subjects (NCT05692934) | Shandong Suncadia Medicine Co., Ltd. | 2023-01-31 |
| Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects (NCT05415644) | Shandong Suncadia Medicine Co., Ltd. | 2022-07-05 |
| A Phase I Single- and Multiple- Ascending Dose and Food Effect Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HRS-7535 in Healthy Subjects (NCT05347758) | Shandong Suncadia Medicine Co., Ltd. | 2022-05-01 |
| A Trial of HRS-8080 Tablets in Metastatic or Local Advanced Breast Cancer of Adults (NCT05189717) | Shandong Suncadia Medicine Co., Ltd. | 2022-02-17 |
| A Study to Assess the Bioequivalence of Fixed Dose Combination of HR20033 Relative to Co-administration of the Individual Components in Healthy Chinese Subjects (NCT05108350) | Shandong Suncadia Medicine Co., Ltd. | 2021-11-09 |
| A Study to Assess the Effect of Food on HR20033 and Pharmacokinetic After Multiple Dose in Healthy Volunteers (NCT05120219) | Shandong Suncadia Medicine Co., Ltd. | 2021-10-13 |